XTLB XTL Biopharmaceuticals Ltd.

NSD
$2.16

XTL Biopharmaceuticals Ltd. (XTLB) is expected to report earnings on October 12, 2026, during market hours.

Earnings Date
Oct 12
Monday · 8:55 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company developing drugs against hepatitis.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.